12.05.2020 • NewsLuciteAgilyxElaine Burridge

Lucite and Agilyx Partner on PMMA

Acrylic-based products manufacturer Lucite International, part of the Mitsubishi Chemical Group, is working with Agilyx to define the most suitable chemical recycling infrastructure for polymethyl methacrylate (PMMA).

Agilyx will apply its depolymerization process to produce a virgin-quality monomer, or methyl methacrylate (MMA).

Lucite’s aim is to bring the technology to commercial realization by 2023, giving PMMA producers the ability to have their products recovered and recycled while also offering consumers fully recycled acrylic products.

In the interim, the UK-based acrylics specialist said it will work with all key stakeholders, including MMA and PMMA customers, manufacturers, distributors, fabricators and recyclers to develop a robust value chain.

Phil Bailey, general manager EMEA strategic business unit at Mitsubishi Chemical, said the company is “committed to ensuring PMMA becomes a fully sustainable material.” He added: “We know from our customers that there is great demand for this, driven by societal and environmental concerns. As global leaders in the MMA industry, we have a responsibility to take the lead in this area.”

In March this year, Lucite announced it would build a 350,000 t/y MMA plant in the US, taking advantage of the country’s favorable shale gas feedstock position. The project, which will use Lucite’s proprietary Alpha technology, is currently in the design phase and expected to be fully operational in 2025.

The company added that the plant will be the third and largest commercial application of its Alpha technology since it was developed and successfully implemented in 2008. It will be fully owned and operated by Mitsubishi Chemical.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.